ISTH Releases Evidence-Based Clinical Practice Guideline for Hemophilia Treatment

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ISTH-Hemophilia

More Like This

PR Newswire associated0

ISTH announces launch of new global education initiative in factor XI/XIa inhibition

PR Newswire associated0

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024

PR Newswire associated0

World Thrombosis Day raises global awareness of blood clot dangers through actionable initiatives

Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China’s First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A

PR Newswire associated0

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

PR Newswire associated0

Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

PR Newswire associated0

EHA: Bridging Breakthroughs in Hematology

PR Newswire associated0

World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwide